Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review

INTRODUCTION: Despite antiretroviral (ARV) therapy reducing renal disease in human immunodeficiency virus overall, there is concern that certain ARVs, particularly tenofovir disoproxil fumarate (TDF) with or without a boosted protease inhibitor (PI), may reduce renal function over time. It is not kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagnis, Corinne Isnard, Stellbrink, Hans-Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363218/
https://www.ncbi.nlm.nih.gov/pubmed/25567681
http://dx.doi.org/10.1007/s40121-014-0056-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363218/
https://www.ncbi.nlm.nih.gov/pubmed/25567681
http://dx.doi.org/10.1007/s40121-014-0056-4

Ejemplares similares